menu
    • menu

    Company profile for Arvelle Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cenobamate (YKP3089) was discovered by SK Biopharmaceuticals and SK life science and is being investigated for the potential treatment of partial-onset seizures (also known as “focal seizures”) in adult patients. Global trials for adults with partial-onset seizures are ongoing to evaluate cenobamate safety. An additional clinical trial is investigating cenobamate safety and efficacy for another form of epilepsy in adult p...
    Cenobamate (YKP3089) was discovered by SK Biopharmaceuticals and SK life science and is being investigated for the potential treatment of partial-onset seizures (also known as “focal seizures”) in adult patients. Global trials for adults with partial-onset seizures are ongoing to evaluate cenobamate safety. An additional clinical trial is investigating cenobamate safety and efficacy for another form of epilepsy in adult patients.The U.S. Food and Drug Administration (FDA) accepted the filing of the New Drug Application for cenobamate for the potential treatment of partial-onset seizures in adults in February 2019.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arvelle TherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Zählerweg 6 6300 Zug
    Telephone
    Telephone
    (888) 317-1041
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.arvelletx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arvelle-therapeutics-inc/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NICE recommends cenobamate for treatment of adult epilepsy patients in UK
    NICE recommends cenobamate for treatment of adult epilepsy patients in UK

    16 Nov 2021

    // PHARMATIMES

    https://www.pharmatimes.com/news/nice_recommends_cenobamate_for_treatment_of_adult_epilepsy_patients_in_uk_1383466

    PHARMATIMES
    16 Nov 2021
    Share Share
    EMA recommends Arvelle's seizure drug cenobamate
    EMA recommends Arvelle's seizure drug cenobamate

    01 Feb 2021

    // PHARMAFILE

    http://www.pharmafile.com/news/570444/ema-recommends-arvelles-seizure-drug-cenobamate

    PHARMAFILE
    01 Feb 2021
    Share Share
    Angelini acquires Arvelle to create a leading European innovator in CNS
    Angelini acquires Arvelle to create a leading European innovator in CNS

    14 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/angelini-pharma-acquires-arvelle-therapeutics-to-create-a-leading-european-innovator-in-central-nervous-system-cns-and-mental-health-disorder-treatments-301207862.html

    PRNEWSWIRE
    14 Jan 2021
    Share Share
    Angelini Pharma acquires Arvelle Therapeutics
    Angelini Pharma acquires Arvelle Therapeutics

    04 Jan 2021

    // PRESS RELEASE

    https://www.angelinipharma.com/media/press-releases/angelini-pharma-acquires-arvelle-therapeutics/

    PRESS RELEASE
    04 Jan 2021
    Share Share
    Arvelle Announces Closing of Final Tranche of Series A Financing Round
    Arvelle Announces Closing of Final Tranche of Series A Financing Round

    27 Oct 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/26/2038483/0/en/Arvelle-Announces-Closing-of-Final-Tranche-of-Series-A-Financing-Round.html

    GLOBENEWSWIRE
    27 Oct 2020
    Share Share
    Arvelle Announces Partnership with Durbin Across Europe
    Arvelle Announces Partnership with Durbin Across Europe

    17 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/17/2078998/0/en/Arvelle-Announces-Partnership-with-Durbin-Across-Europe.html#:~:text=Zug%2C%20Switzerland%2C%2017%20August%202020,for%20the%20distribution%20of%20cenobamate

    GLOBENEWSWIRE
    17 Aug 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search